NCT07270757Recruiting
Impact of Pre-Ablation Prehabilitation on Clinical Outcomes and Cardiorespiratory Fitness in Atrial Fibrillation Patients
Impact of Pre-Ablation Prehabilitation on Clinical Outcomes and Cardiorespiratory Fitness in Patients With Atrial Fibrillation: A Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 8 Dec 2025
Brief summary (registry, in English)
The primary objective of this study is to compare the effects of a preoperative prehabilitation program versus usual care on post-procedural cardiorespiratory function and clinical outcomes in patients undergoing catheter ablation for atrial fibrillation.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- First submitted
- 26 Nov 2025
- Start date
- 1 Feb 2025
- Primary completion date
- Feb 2026
- Lead sponsor
- Nanjing Medical University
- Diseases
- Atrial fibrillation
- NCT number
- NCT07270757
What you commit to
- Study type: Interventional
- Planned participants: 100
- From 1 Feb 2025 to the primary completion date, Feb 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Significant structural heart disease (e.g., severe valvular disease)
- Cognitive impairment preventing cooperation
Other
- Contraindications to CPET or exercise training
Who the study is looking for
- Aged 18-70 years
- Scheduled for first AF ablation
- NYHA class I-II
- LVEF ≥ 50%
Age in the registry: 18 years to 70 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The First Affiliated Hospital with Nanjing Medical University Coordinator of this site? Confirm its status | Nanjing | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.